DUBLIN--(BUSINESS WIRE)--The "Polycystic Kidney Disease - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
This report offers a comprehensive insight of the pipeline (under development) therapeutics scenario and growth prospects across Polycystic Kidney Disease development.
The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
Pipeline Products covered across the following Developmental Stages:
- Clinical
- Non-clinical
- Inactive: Discontinued and/or Dormant
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.
The report assesses the active Polycystic Kidney Disease pipeline products by developmental stage, product type, molecule type, and administration route.
Scope
- The report provides a snapshot of the pipeline development for the Polycystic Kidney Disease
- The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Polycystic Kidney Disease
- The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Polycystic Kidney Disease
-
The report also covers the dormant and discontinued pipeline projects
related to the Polycystic Kidney Disease
Companies Featured
- 3SBio Inc
- Angion Biomedica Corp
- Aptevo Therapeutics Inc
- Conatus Pharmaceuticals Inc
- DiscoveryBiomed Inc
- Endocyte Inc
- Kadmon Corp LLC
- ManRos Therapeutics
- Mironid Ltd
- NovaTarg Therapeutics Inc
- Otsuka Holdings Co Ltd
Key Topics Covered
1. Report Introduction
2. Polycystic Kidney Disease Overview
3. Pipeline Therapeutics
4. Comparative Analysis
5. Products in Clinical Stage
6. Products in Pre-Clinical and Discovery Stage
7. Therapeutic Assessment
8. Inactive Products
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/cp7hmn/polycystic_kidney?w=4
